Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04834778
Title A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors HiberCell, Inc.
Indications

gastric adenocarcinoma

Her2-receptor positive breast cancer

papillary renal cell carcinoma

lung small cell carcinoma

clear cell renal cell carcinoma

Therapies

HC-5404-FU

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.